TOEIC考試專家
收藏本站
 
      
  • 多益單字,多益閱讀,多益聽力,多益文法,多益考古題,多益英文,多益網,雅思網,多益學習,多益題庫,多益課程,多益名師,雅思名師,多益攻略,新多益準備,多益字彙,多益推薦 
  • 雅思單字,雅思閱讀,雅思聽力,雅思口說,雅思考古題,雅思英文,雅思網,多益網,雅思學習,雅思題庫,雅思課程,多益名師,雅思名師,雅思攻略,雅思準備,雅思字彙,雅思推薦 
      
  • 多益top1名師 陳蕙,旋元佑,文喬,莫平所領軍 多益.托福.雅思.英檢學習網,推薦課程有文法,單字,閱讀,聽力,口說,寫作,企業內部特訓,高分秘訣等教材 助您輕鬆應對考試 
  • 托福top1名師 陳蕙,旋元佑,文喬,莫平所領軍 多益.托福.雅思.英檢學習網,推薦課程有文法,單字,閱讀,聽力,口說,寫作,企業內部特訓,高分秘訣等教材 助您輕鬆應對考試 
  • 雅思top1名師 陳蕙,旋元佑,文喬,莫平所領軍 多益.托福.雅思.英檢學習網,推薦課程有文法,單字,閱讀,聽力,口說,寫作,企業內部特訓,高分秘訣等教材 助您輕鬆應對考試 
  • 英檢top1名師 陳蕙,旋元佑,文喬,莫平所領軍 多益.托福.雅思.英檢學習網,推薦課程有文法,單字,閱讀,聽力,口說,寫作,企業內部特訓,高分秘訣等教材 助您輕鬆應對考試 
 本網站由多益名師陳蕙,旋元佑,文喬,莫平四大天王所領軍  長久以來,在英文補習界掀起一陣『實力派』的旋風,完全取代其他補習班雜亂無章的講義猜題教學,締造眾多學員傲人的成績也是其他補習班遠所不及  絕對不是僥倖或廣告,而是口碑不斷流傳的自然結果,多益的教學成績是這個好口碑的最基本證據,也是學生前途的最佳保障。 
新聞詳情
雅思聽力口語(VOA)聽抄訓練 - 心臟病人更喜歡服用多效藥丸
瀏覽數:429

那些有心臟病或中風風險的病人可能會服用大量的藥片,有的藥可以降血壓,有的可以控制膽固醇,還有的可以用來預防心臟病。

Henryk Pycz同時身患高血壓和糖尿病,他參加了一項研究,來看看是否可以通過控制所服用藥片的數量來達到更好的療效。

當你服用含有幾種藥片的藥物時,實際上是服用了五、六甚至七片藥。

倫敦帝國學院國家心肺研究所的西蒙·托姆博士知道,要病人來管理好這些藥物是不容易的。

我們知道在預防性藥物的覆蓋面和繼續使用程度上存在很大缺口,尤其在中低收入國家。

托姆博士負責了一項涉及2000多病人的研究,其中幾乎90%的患者患有中風或心臟病,其他10%很有可能患上這些病。一半的參加者得到名為多效藥丸的複合日常用藥,含有抑制素、血壓藥和另一種很像阿司匹林的用於預防血液阻塞的藥物。其他的參加者被告知繼續服用常規的藥物。托姆博士說結果明顯表明多效藥丸更好。

在試驗的最後階段,與常規用藥的小組相比,那些服用多效藥丸小組的病人有更多人根據醫囑服藥。

那些服用多效藥丸的病人在控制血壓和膽固醇方面都有改善,Pycz說自己學到一些東西。

這次試驗讓我明白,控制自己的用藥很重要。多效藥丸意味著永遠不會出錯,總能服用正確的藥量。

托姆博士說這項研究有著重大意義,尤其對於那些錯過用藥的病人來說。

多效藥丸帶來了巨大的公共衛生機會,來彌合用藥不足和有效使用治療性藥物的缺口。

托姆博士說,這是因為,那些遵照醫囑服藥並得到最大療效的病人最可能在試驗的開始階段就忽略服藥。

這項研究發表在雜誌《美國醫藥協會》上。

WASHINGTON — Many patients who have heart disease or who have suffered a stroke don’t take their medications as regularly as prescribed. One study shows that a number of stroke patients stop taking their pills within three months after having a stroke. A new study in Britain finds that if patients with heart disease can take a single pill instead of several pills, they are more likely to stay on their medication.

Patients at risk for heart attack or stroke may be taking a lot of pills. Some could reduce blood pressure. Other pills could control cholesterol. Still others might be prescribed to prevent a heart attack.

Henryk Pycz, who has both high blood pressure and diabetes, participated in a study to see if he could do better in managing his health by reducing the number of pills he had to take.

"When I was taking the medication consisting of a variety of tablets, I'd have either five, six or seven tablets to take," he said.

Dr. Simon Thom, from the National Heart and Lung Institute at the Imperial College in London, knew it was hard for patients to manage all those medications.

"We know there's a big shortfall in the coverage and continued usage of preventative medication, particularly in lower middle income countries," he said.

Dr. Thom led a study that involved more than 2,000 patients. Almost 90 percent of them had suffered a stroke or had heart disease. The other 10 percent had a high risk of having one. Half of the participants received a combination daily medication known as a polypill that contained statins, blood pressure medication and another drug like aspirin to prevent blood clots. The other participants were told to continue taking their regular medications. Dr. Thom says the results clearly favored the polypill.

“More patients at the end of the trial were taking indicated medications in the form of the fixed dose combination polypill than were in the usual care group,” he said.

The patients who took the polypill had improvements in control of both blood pressure and cholesterol. Pycz said he also learned something.

"It helped me to understand that controlling your medication is important. The polypill meant that I was never out of sync I always had the correct amount of tablets to take,” he said.

Dr. Thom says the study has huge implications, especially for those who skip their medications.

“The polypill has a big public health opportunity to bridge the gap of under usage of indicated and effective therapeutic medication,” he said.

Dr. Thom says that's because those who made the biggest gains in taking in taking their medications as prescribed were the ones who were most likely to skip them at the beginning of the trial.

The study appears in the Journal of the American Medical Association.

世界各國語言網頁翻譯